Accessibility Menu
 
cbdMD logo

cbdMD

(NYSEMKT) YCBD

Current Price$0.70
Market Cap$7.79M
Since IPO (2018)-100%
5 Year-100%
1 Year-60%
1 Month-19%

cbdMD Financials at a Glance

Market Cap

$7.79M

Revenue (TTM)

$19.09M

Net Income (TTM)

$2.34M

EPS (TTM)

$-2.23

P/E Ratio

-0.33

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$0.70

Volume

10,400

Open

$0.72

Previous Close

$0.70

Daily Range

$0.70 - $0.78

52-Week Range

$0.47 - $2.64

YCBD News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About cbdMD

Industry

Pharmaceuticals

Employees

42

CEO

T. Ronan Kennedy, MBA

Headquarters

Charlotte, NC 28217, US

YCBD Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

-12%

Net Income Margin

-12%

Return on Equity

-43%

Return on Capital

-26%

Return on Assets

-20%

Earnings Yield

-3.03%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$7.79M

Shares Outstanding

10.50M

Volume

10.40K

Short Interest

0.00%

Avg. Volume

1.07M

Financials (TTM)

Gross Profit

$10.84M

Operating Income

$2.16M

EBITDA

$366.67K

Operating Cash Flow

$1.45M

Capital Expenditure

$184.18K

Free Cash Flow

$1.64M

Cash & ST Invst.

$2.26M

Total Debt

$778.24M

cbdMD Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$5.02M

-1.9%

Gross Profit

$2.76M

-11.2%

Gross Margin

54.93%

N/A

Market Cap

$7.79M

N/A

Market Cap/Employee

$185.42K

N/A

Employees

42

N/A

Net Income

$283.13K

-1975.7%

EBITDA

$130.34K

-48.5%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$589.64M

-171084.9%

Accounts Receivable

$1.12M

-12.2%

Inventory

$3.14M

+48.6%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$593.03M

+57264.5%

Return on Assets

-19.85%

N/A

Return on Invested Capital

-26.23%

N/A

Free Cash Flow

$164.80M

-34067.5%

Operating Cash Flow

$812.46K

-155.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBFMSunshine Biopharma, Inc.
$1.09+5.29%
BFRIBiofrontera Inc.
$0.92+13.83%
FLGCFlora Growth Corp.
$7.79-32.14%
SNOASonoma Pharmaceuticals, Inc.
$2.43+14.08%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$6.38+3.12%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.45-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%

Questions About YCBD

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.